TrialMolecular psychiatry2020

A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.

G I Papakostas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.